NIH-funded research R01 grant

Ultrasound imaging to detect and monitor pancreatic changes in type 1 diabetes

Official title: Developing ultrasound contrast agents and signal processing for structural and functional imaging in type 1 diabetes

Funded at University of Colorado Denver · NIH-11332626 · Data updated 2026-11-12

A study using advanced ultrasound contrast and high-resolution imaging to see early signs of type 1 diabetes in the pancreas, with the goal of guiding potential treatments.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startJune 1, 2024
Project endMay 31, 2028
Funding year2026
Award (this year)$632,022
NIH project number5R01DK140904-03
Project IDNIH-11332626 on NIH RePORTER

Who could benefit from this research

Could help

People at risk for type 1 diabetes or in the pre-symptomatic phase who may undergo imaging with specialized ultrasound techniques.

Less likely to help

Patients without early pancreatic inflammation or those unable to undergo ultrasound with contrast agents may not benefit.

What this research studies

This project aims to use ultrasound with special gas-filled contrast agents to visualize tiny blood vessels in the pancreas and detect early changes associated with type 1 diabetes. By applying ultrasound localization microscopy, researchers hope to see disease signatures in the islets of Langerhans that are usually hidden within the whole pancreas. The study builds on prior work in animal models and focuses on translating high-resolution imaging to humans to identify the pre-symptomatic phase of T1D. The research could ultimately help tailor interventions during the silent period before symptoms arise.

Why it matters

Potential benefit: If successful, this work could enable earlier detection of T1D-related changes and guide timely therapeutic decisions.

How similar studies have gone: Preclinical studies using contrast-enhanced ultrasound showed potential in detecting insulitis, but this approach in humans is still being established.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Benninger, Richard Kp — University of Colorado Denver
  • Study coordinator: Benninger, Richard Kp

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.